| 产品详情 |
| Edit |   |
| Product Name | AZD-9291 mesylate |
| Description | AZD9291 is a potent, selective, and irreversible, third generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It inhibits EGFR phosphorylation in EGFR-bearing cells harboring sensitizing EGFR mutants with mean IC50 values ranging from 13 to 54 nM. It also potently inhibits phosphorylation of EGFR in T790M+ mutant cell lines. AZD-9291 displays profound and sustained tumor regression in EGFR-mutant tumor xenograft and transgenic models. MW: 595.71. Purity ≥98% by HPLC |
| Size | 25 mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | (Z)-N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylimidic acid methnanesulfonic acid; Osimertinib, methanesulfonate |
| Gene, Accession, CAS # | CAS: 1421373-66-1 |
| Catalog # | B1899-25 |
| Price | |
| Order / More Info | AZD-9291 mesylate from BIOVISION, INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|